Verastem (VSTM) News Today $4.78 +0.14 (+3.02%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Verastem (NASDAQ:VSTM) Research Coverage Started at Jefferies Financial GroupApril 13 at 1:25 AM | americanbankingnews.comMizuho Cuts Verastem (NASDAQ:VSTM) Price Target to $8.00April 12 at 1:49 AM | americanbankingnews.comMizuho Lowers Verastem (NASDAQ:VSTM) Price Target to $8.00Mizuho lowered their price objective on Verastem from $9.00 to $8.00 and set an "outperform" rating for the company in a research report on Wednesday.April 11 at 9:23 AM | marketbeat.comVerastem initiated with a Buy at JefferiesApril 11 at 12:29 AM | markets.businessinsider.comVerastem: RAMP-203 Study Could Be Next Big Win For Avutometinib CombinationApril 10, 2025 | seekingalpha.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Recursion Pharmaceuticals (RXRX), Masimo (MASI) and Verastem (VSTM)April 10, 2025 | markets.businessinsider.comVerastem initiated Buy at Jefferies on a potential FDA nod for ovarian cancer therapyApril 10, 2025 | msn.comJefferies Initiates Coverage of Verastem (VSTM) with Buy RecommendationApril 10, 2025 | msn.comVerastem (VSTM) Receives Buy Rating from Jefferies with Promising Outlook | VSTM Stock NewsApril 10, 2025 | gurufocus.comVerastem (NASDAQ:VSTM) Share Price Crosses Above 200-Day Moving Average - What's Next?Verastem (NASDAQ:VSTM) Shares Cross Above 200-Day Moving Average - Here's WhyApril 10, 2025 | marketbeat.comVerastem price target lowered to $8 from $9 at MizuhoApril 10, 2025 | markets.businessinsider.comVerastem (VSTM) Receives a Buy from Mizuho SecuritiesApril 9, 2025 | markets.businessinsider.comVerastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 7, 2025 | gurufocus.comVerastem Oncology Reports Progress in Cancer TreatmentsApril 3, 2025 | tipranks.comVerastem, Inc. (NASDAQ:VSTM) Short Interest UpdateVerastem, Inc. (NASDAQ:VSTM - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 7,320,000 shares, a growth of 22.8% from the February 28th total of 5,960,000 shares. Currently, 16.0% of the shares of the stock are sold short. Based on an average daily volume of 1,330,000 shares, the days-to-cover ratio is presently 5.5 days.April 2, 2025 | marketbeat.comAIGH Capital Management LLC Purchases Shares of 2,665,043 Verastem, Inc. (NASDAQ:VSTM)AIGH Capital Management LLC acquired a new position in shares of Verastem, Inc. (NASDAQ:VSTM - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,665,043 shares of the biopharmaceutical company's stock,March 31, 2025 | marketbeat.comResearch Analysts Offer Predictions for Verastem Q1 EarningsVerastem, Inc. (NASDAQ:VSTM - Free Report) - Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Verastem in a research note issued to investors on Monday, March 24th. HC Wainwright analyst S. Lee anticipates that the biopharmaceutical company will post earnings of ($0March 28, 2025 | marketbeat.comVerastem (NASDAQ:VSTM) Upgraded to "Hold" at StockNews.comStockNews.com raised Verastem from a "sell" rating to a "hold" rating in a research note on Monday.March 25, 2025 | marketbeat.comVerastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025March 25, 2025 | businesswire.comVerastem (NASDAQ:VSTM) Price Target Raised to $14.00Guggenheim increased their price objective on Verastem from $13.00 to $14.00 and gave the company a "buy" rating in a report on Monday.March 25, 2025 | marketbeat.comVerastem (NASDAQ:VSTM) Given New $10.00 Price Target at HC WainwrightHC Wainwright raised their price target on shares of Verastem from $7.00 to $10.00 and gave the stock a "buy" rating in a research report on Monday.March 25, 2025 | marketbeat.comVerastem price target raised to $14 from $13 at GuggenheimMarch 24, 2025 | markets.businessinsider.comVerastem CFO Daniel Calkins sells shares worth $630March 24, 2025 | investing.comVerastem price target raised to $10 from $7 at H.C. WainwrightMarch 24, 2025 | markets.businessinsider.comVerastem’s Promising Financial Outlook and Strategic Advancements Drive Buy RatingMarch 24, 2025 | tipranks.comRosalind Advisors Inc. Takes Position in Verastem, Inc. (NASDAQ:VSTM)Rosalind Advisors Inc. purchased a new stake in Verastem, Inc. (NASDAQ:VSTM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 900,000 shares of the biopharmaceutical company's stock, valued at approximatMarch 23, 2025 | marketbeat.comAlliance Global Partners Remains a Buy on Verastem (VSTM)March 22, 2025 | markets.businessinsider.comRoyal Bank of Canada Has Lowered Expectations for Verastem (NASDAQ:VSTM) Stock PriceRoyal Bank of Canada dropped their price target on shares of Verastem from $16.00 to $14.00 and set an "outperform" rating for the company in a research note on Friday.March 22, 2025 | marketbeat.comBTIG Sticks to Its Buy Rating for Verastem (VSTM)March 21, 2025 | markets.businessinsider.comVerastem price target lowered to $14 from $16 at RBC CapitalMarch 21, 2025 | markets.businessinsider.comVerastem (NASDAQ:VSTM) Issues Quarterly Earnings ResultsVerastem (NASDAQ:VSTM - Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.76) by ($0.57).March 21, 2025 | marketbeat.comVerastem (NASDAQ:VSTM) Announces Quarterly Earnings ResultsVerastem (NASDAQ:VSTM - Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.33) earnings per share for the quarter, missing analysts' consensus estimates of ($0.76) by ($0.57).March 21, 2025 | marketbeat.comVerastem reports Q4 EPS (60c), consensus (74c)March 21, 2025 | markets.businessinsider.comVerastem files to sell 1.42M shares of common stock for holdersMarch 21, 2025 | markets.businessinsider.comVerastem Unveils Strategic Plans in New PresentationMarch 20, 2025 | tipranks.comVerastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights ...March 20, 2025 | gurufocus.comVerastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of "Buy" from BrokeragesShares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have been assigned an average recommendation of "Buy" from the nine ratings firms that are currently covering the company, Marketbeat reports. Nine analysts have rated the stock with a buy rating. The average 12 month target price among brokMarch 20, 2025 | marketbeat.comVerastem CEO sells shares worth $1,695March 19, 2025 | investing.comVerastem (NASDAQ:VSTM) Stock Passes Above 200-Day Moving Average - Here's WhyVerastem (NASDAQ:VSTM) Stock Crosses Above Two Hundred Day Moving Average - What's Next?March 19, 2025 | marketbeat.comVerastem: Upcoming PDUFA, But I Remain CautiousMarch 11, 2025 | seekingalpha.comVerastem (VSTM) to Release Quarterly Earnings on ThursdayVerastem (NASDAQ:VSTM) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 11, 2025 | marketbeat.comVerastem (VSTM) Expected to Announce Earnings on ThursdayVerastem (NASDAQ:VSTM) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comVerastem (NASDAQ:VSTM) Stock Price Passes Above 200 Day Moving Average - Should You Sell?Verastem (NASDAQ:VSTM) Share Price Passes Above 200 Day Moving Average - Should You Sell?March 4, 2025 | marketbeat.comVerastem, Inc. (NASDAQ:VSTM) Given Consensus Rating of "Buy" by BrokeragesVerastem, Inc. (NASDAQ:VSTM - Get Free Report) has been given a consensus recommendation of "Buy" by the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating. The average 12 month price objective amFebruary 23, 2025 | marketbeat.comVerastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s CancerFebruary 21, 2025 | finance.yahoo.comAlyeska Investment Group Reduces Stake in Verastem IncFebruary 15, 2025 | gurufocus.comNantahala Capital Management, LLC Increases Stake in Verastem IncFebruary 15, 2025 | gurufocus.comVerastem CEO Dan Paterson sells shares worth $4,890February 5, 2025 | msn.comVerastem price target raised to $9 from $7 at B. RileyJanuary 31, 2025 | markets.businessinsider.comVanguard Group Inc. Increases Stake in Verastem Inc.January 31, 2025 | gurufocus.com Remove Ads Get Verastem News Delivered to You Automatically Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter. Email Address VSTM Media Mentions By Week VSTM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VSTM News Sentiment▼0.151.00▲Average Medical News Sentiment VSTM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VSTM Articles This Week▼154▲VSTM Articles Average Week Remove Ads Get Verastem News Delivered to You Automatically Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Celldex Therapeutics News OPKO Health News Geron News Myriad Genetics News Zenas Biopharma News Rigel Pharmaceuticals News Vanda Pharmaceuticals News Emergent BioSolutions News XOMA News Ironwood Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VSTM) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verastem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verastem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VSTM Stock Free VSTM Stock Alerts